Healthcare provider profile · identity verified

Alex V Stock, MD

Family Practice · CONCORD, NC · NPI 1467573980

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	239	72
Levothyroxine Sodium	Levothyroxine Sodium	200	59
Amlodipine Besylate	Amlodipine Besylate	182	56
Lisinopril	Lisinopril	173	48
Omeprazole	Omeprazole	151	45
Pantoprazole Sodium	Pantoprazole Sodium	143	38
Rosuvastatin Calcium	Rosuvastatin Calcium	143	44
Alprazolam	Alprazolam	135	26
Gabapentin	Gabapentin	134	34
Metformin Hcl	Metformin Hcl	111	31
Albuterol Sulfate Hfa	Albuterol Sulfate	110	29
Trazodone Hcl	Trazodone Hcl	110	33
Eliquis	Apixaban	104	16
Valsartan	Valsartan	97	31
Metoprolol Succinate	Metoprolol Succinate	92	26
Furosemide	Furosemide	89	25
Losartan Potassium	Losartan Potassium	87	25
Clopidogrel	Clopidogrel Bisulfate	81	17
Fluticasone Propionate	Fluticasone Propionate	80	28
Metformin Hcl Er	Metformin Hcl	80	19
Tramadol Hcl	Tramadol Hcl	77	17
Sertraline Hcl	Sertraline Hcl	76	20
Tamsulosin Hcl	Tamsulosin Hcl	76	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	71	23
Metoprolol Tartrate	Metoprolol Tartrate	70	22
Celecoxib	Celecoxib	68	25
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	68	19
Potassium Chloride	Potassium Chloride	67	18
Hydrochlorothiazide	Hydrochlorothiazide	66	26
Zolpidem Tartrate	Zolpidem Tartrate	66	22
Pravastatin Sodium	Pravastatin Sodium	65	19
Bupropion Xl	Bupropion Hcl	64	11
Duloxetine Hcl	Duloxetine Hcl	64	16
Simvastatin	Simvastatin	56	18
Escitalopram Oxalate	Escitalopram Oxalate	55	22
Montelukast Sodium	Montelukast Sodium	54	14
Lorazepam	Lorazepam	53	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	50	suppressed
Spironolactone	Spironolactone	47	13
Clonazepam	Clonazepam	46	13
Ipratropium Bromide	Ipratropium Bromide	46	12
Meloxicam	Meloxicam	46	13
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	45	suppressed
Baclofen	Baclofen	42	12
Famotidine	Famotidine	41	12
Quetiapine Fumarate	Quetiapine Fumarate	39	suppressed
Jardiance	Empagliflozin	38	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	38	11
Carvedilol	Carvedilol	37	11
Oxycodone Hcl	Oxycodone Hcl	37	suppressed
Clonidine Hcl	Clonidine Hcl	35	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	35	suppressed
Glimepiride	Glimepiride	34	13
Allopurinol	Allopurinol	32	11
Aripiprazole	Aripiprazole	32	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Trulicity	Dulaglutide	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	12
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Atenolol	Atenolol	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Latanoprost	Latanoprost	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	22	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Ondansetron Odt	Ondansetron	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Torsemide	Torsemide	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Cefdinir	Cefdinir	17	17
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Linzess	Linaclotide	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	11
Donepezil Hcl	Donepezil Hcl	15	suppressed
Risperidone	Risperidone	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Carisoprodol	Carisoprodol	14	suppressed
Promethazine Hcl	Promethazine Hcl	14	suppressed
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Diazepam	Diazepam	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	12
Farxiga	Dapagliflozin Propanediol	13	suppressed
Nystatin	Nystatin	13	suppressed
Azithromycin	Azithromycin	12	12
Flecainide Acetate	Flecainide Acetate	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Progesterone	Progesterone, Micronized	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Clindamycin Hcl	Clindamycin Hcl	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Ozempic	Semaglutide	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error